Champions Oncology, Inc. SEC filings CSBR

Champions Oncology, Inc. has 655 filings in SEC EDGAR's recent list, going back to Sep 13, 1995. Its latest annual report, Form 10-K, was filed on Jul 27, 2026 for the period ended Apr 30, 2026. The latest quarterly report (Form 10-Q) was filed on Sep 11, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (shareholder vote results). The company's fiscal year ends on April 30.

Champions Oncology, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Oct 16, 2026 Oct 15, 2026
8-K Current report
Shareholder vote results
Oct 16, 2026 Oct 14, 2026
10-Q Quarterly report Sep 11, 2026 Jul 31, 2026
8-K Current report
Results of operations
Sep 10, 2026 Sep 10, 2026
DEFA14A Additional proxy material Aug 28, 2026 —
DEF 14A Proxy statement Aug 28, 2026 Aug 27, 2026
10-K Annual report Jul 27, 2026 Apr 30, 2026
8-K Current report
Results of operations
Jul 27, 2026 Jul 27, 2026
8-K Current report
Officer or director change
Mar 30, 2026 Mar 24, 2026
10-Q Quarterly report Mar 12, 2026 Jan 31, 2026
8-K Current report
Results of operations
Mar 12, 2026 Mar 12, 2026
4 Insider transaction Jan 30, 2026 Jul 16, 2025
4 Insider transaction Jan 30, 2026 Nov 5, 2021
3 Initial insider ownership Jan 16, 2026 Jun 9, 2021
10-Q Quarterly report Dec 15, 2025 Oct 31, 2025
8-K Current report
Results of operations
Dec 15, 2025 Dec 15, 2025
4 Insider transaction Nov 7, 2025 Nov 5, 2025
4 Insider transaction Nov 7, 2025 Nov 5, 2025
4 Insider transaction Nov 7, 2025 Nov 5, 2025
4 Insider transaction Nov 7, 2025 Nov 5, 2025
4 Insider transaction Nov 7, 2025 Nov 5, 2025
4 Insider transaction Nov 6, 2025 Oct 30, 2025
8-K Current report
Shareholder vote results
Oct 16, 2025 Oct 16, 2025
10-Q Quarterly report Sep 15, 2025 Jul 31, 2025
8-K Current report
Results of operations
Sep 15, 2025 Sep 15, 2025
DEFA14A Additional proxy material Aug 22, 2025 —
DEF 14A Proxy statement Aug 22, 2025 Aug 22, 2025
10-K Annual report Jul 23, 2025 Apr 30, 2025
8-K Current report
Results of operations
Jul 23, 2025 Jul 23, 2025
8-K Current report Jul 21, 2025 Jul 21, 2025
4 Insider transaction Apr 2, 2025 Mar 25, 2025
10-Q Quarterly report Mar 17, 2025 Jan 31, 2025
8-K Current report
Results of operations
Mar 11, 2025 Mar 11, 2025
UPLOAD Letter from the SEC Mar 4, 2025 —
CORRESP Letter to the SEC Mar 3, 2025 —
UPLOAD Letter from the SEC Feb 26, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
10-Q Quarterly report Dec 16, 2024 Oct 31, 2024
8-K Current report
Results of operations
Dec 11, 2024 Dec 11, 2024
4 Insider transaction Nov 18, 2024 Nov 12, 2024
4 Insider transaction Nov 18, 2024 Nov 12, 2024
4 Insider transaction Nov 18, 2024 Nov 12, 2024
4 Insider transaction Nov 18, 2024 Nov 12, 2024
4 Insider transaction Nov 18, 2024 Nov 12, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
4 Insider transaction Nov 1, 2024 Oct 31, 2024
S-8 Employee stock plan registration Oct 30, 2024 —
8-K Current report
Shareholder vote results
Oct 15, 2024 Oct 14, 2024
8-K Current report
Officer or director change
Oct 3, 2024 Oct 3, 2024
10-Q Quarterly report Sep 13, 2024 Jul 31, 2024
8-K Current report
Results of operations
Sep 11, 2024 Sep 11, 2024
DEFA14A Additional proxy material Aug 27, 2024 —
DEF 14A Proxy statement Aug 27, 2024 Aug 27, 2024
10-K Annual report Jul 19, 2024 Apr 30, 2024
8-K Current report
Results of operations
Jul 18, 2024 Jul 18, 2024
SC 13D/A Amended ownership over 5% (active) May 6, 2024 —
4 Insider transaction Apr 1, 2024 Oct 9, 2023
10-Q Quarterly report Mar 15, 2024 Jan 31, 2024
8-K Current report
Results of operations
Mar 12, 2024 Mar 12, 2024
SC 13G Ownership over 5% (passive) Feb 12, 2024 —
4 Insider transaction Jan 16, 2024 Jan 12, 2024
4 Insider transaction Jan 12, 2024 Jan 11, 2024
4 Insider transaction Jan 11, 2024 Jan 10, 2024
4 Insider transaction Jan 10, 2024 Jan 9, 2024
4 Insider transaction Jan 9, 2024 Jan 8, 2024
4 Insider transaction Jan 8, 2024 Jan 5, 2024
4 Insider transaction Jan 8, 2024 Jan 4, 2024
4 Insider transaction Jan 5, 2024 Oct 17, 2023
4 Insider transaction Jan 4, 2024 Jan 3, 2024
4 Insider transaction Dec 26, 2023 Dec 21, 2023
4 Insider transaction Dec 21, 2023 Dec 20, 2023
4 Insider transaction Dec 20, 2023 Dec 19, 2023
10-Q Quarterly report Dec 13, 2023 Oct 31, 2023
8-K Current report
Results of operations
Dec 12, 2023 Dec 12, 2023
4 Insider transaction Nov 7, 2023 Nov 3, 2023
4 Insider transaction Nov 7, 2023 Nov 3, 2023
4 Insider transaction Nov 7, 2023 Nov 3, 2023
4 Insider transaction Nov 7, 2023 Nov 3, 2023
4 Insider transaction Nov 7, 2023 Nov 3, 2023
8-K Current report
Shareholder vote results
Oct 19, 2023 Oct 19, 2023
8-K Current report
Officer or director change
Oct 17, 2023 Oct 9, 2023
4 Insider transaction Oct 16, 2023 Sep 29, 2023
4 Insider transaction Oct 16, 2023 Sep 28, 2023
4 Insider transaction Oct 16, 2023 Sep 27, 2023
4 Insider transaction Oct 13, 2023 Oct 11, 2023
4 Insider transaction Oct 11, 2023 Oct 10, 2023
4 Insider transaction Oct 10, 2023 Oct 6, 2023
4 Insider transaction Oct 6, 2023 Oct 5, 2023
4 Insider transaction Oct 4, 2023 Oct 3, 2023
4 Insider transaction Oct 4, 2023 Oct 4, 2023
4 Insider transaction Sep 27, 2023 Sep 26, 2023
4 Insider transaction Sep 25, 2023 Sep 19, 2023
4 Insider transaction Sep 25, 2023 Sep 20, 2023
4 Insider transaction Sep 25, 2023 Sep 21, 2023
4 Insider transaction Sep 25, 2023 Sep 22, 2023
10-Q Quarterly report Sep 13, 2023 Jul 31, 2023
8-K Current report
Results of operations
Sep 13, 2023 Sep 13, 2023
DEFA14A Additional proxy material Aug 28, 2023 —
DEF 14A Proxy statement Aug 28, 2023 Aug 28, 2023
4 Insider transaction Aug 17, 2023 Nov 1, 2022
4 Insider transaction Aug 17, 2023 Nov 1, 2022
4 Insider transaction Aug 17, 2023 Nov 1, 2022
4 Insider transaction Aug 17, 2023 Nov 1, 2022
4 Insider transaction Aug 17, 2023 Nov 1, 2022
10-K Annual report Jul 24, 2023 Apr 30, 2023
8-K Current report
Results of operations
Jul 24, 2023 Jul 24, 2023
8-K Current report
Regulation FD disclosure, Other events
Apr 5, 2023 Apr 5, 2023
4 Insider transaction Mar 21, 2023 Mar 17, 2023
10-Q Quarterly report Mar 16, 2023 Jan 31, 2023
8-K Current report
Results of operations
Mar 15, 2023 Mar 15, 2023
10-Q Quarterly report Dec 13, 2022 Oct 31, 2022
8-K Current report
Results of operations
Dec 13, 2022 Dec 13, 2022
4 Insider transaction Oct 20, 2022 Oct 19, 2022
8-K Current report
Shareholder vote results
Oct 20, 2022 Oct 20, 2022
4 Insider transaction Oct 14, 2022 Oct 12, 2022
4 Insider transaction Oct 14, 2022 Oct 12, 2022
4 Insider transaction Oct 13, 2022 Oct 12, 2022
10-Q Quarterly report Sep 12, 2022 Jul 31, 2022
8-K Current report
Results of operations
Sep 8, 2022 Sep 8, 2022
DEF 14A Proxy statement Aug 31, 2022 Aug 29, 2022
DEF 14A Proxy statement Aug 29, 2022 Aug 29, 2022
DEFC14A Filing Aug 29, 2022 —
10-K Annual report Jul 22, 2022 Apr 30, 2022
8-K Current report
Results of operations
Jul 21, 2022 Jul 21, 2022
10-Q Quarterly report Mar 15, 2022 Jan 31, 2022
8-K Current report
Results of operations
Mar 15, 2022 Mar 15, 2022
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2022 —
10-Q Quarterly report Dec 13, 2021 Oct 31, 2021
8-K Current report
Results of operations
Dec 13, 2021 Dec 13, 2021
4 Insider transaction Nov 9, 2021 Nov 5, 2021
4 Insider transaction Nov 9, 2021 Nov 5, 2021
4 Insider transaction Nov 9, 2021 Nov 5, 2021
4 Insider transaction Nov 9, 2021 Nov 5, 2021
4 Insider transaction Nov 9, 2021 Nov 5, 2021
8-K Current report
Shareholder vote results
Oct 21, 2021 Oct 20, 2021
4 Insider transaction Oct 19, 2021 Oct 15, 2021
4 Insider transaction Oct 13, 2021 Oct 12, 2021
10-Q Quarterly report Sep 13, 2021 Jul 31, 2021
8-K Current report
Results of operations
Sep 13, 2021 Sep 13, 2021
DEFA14A Additional proxy material Sep 1, 2021 —
DEF 14A Proxy statement Aug 30, 2021 Aug 30, 2021
10-K Annual report Jul 26, 2021 Apr 30, 2021
SC 13G Ownership over 5% (passive) Jul 23, 2021 —
8-K Current report
Results of operations
Jul 22, 2021 Jul 22, 2021
4 Insider transaction Mar 25, 2021 Mar 23, 2021
10-Q Quarterly report Mar 15, 2021 Jan 31, 2021
8-K Current report
Results of operations
Mar 11, 2021 Mar 5, 2021
8-K Current report
Officer or director change
Feb 12, 2021 Feb 12, 2021
4 Insider transaction Feb 8, 2021 Jan 19, 2021
4 Insider transaction Dec 17, 2020 Dec 16, 2020
10-Q Quarterly report Dec 14, 2020 Oct 31, 2020
8-K Current report
Results of operations
Dec 14, 2020 Dec 14, 2020
4 Insider transaction Dec 10, 2020 Dec 8, 2020
4 Insider transaction Dec 10, 2020 Dec 8, 2020
4 Insider transaction Dec 10, 2020 Dec 8, 2020
4 Insider transaction Dec 10, 2020 Dec 8, 2020
4 Insider transaction Dec 10, 2020 Dec 8, 2020
4 Insider transaction Dec 10, 2020 Dec 8, 2020
4 Insider transaction Nov 3, 2020 Mar 3, 2020
4 Insider transaction Nov 3, 2020 Feb 18, 2020
4 Insider transaction Nov 3, 2020 Feb 11, 2020
4 Insider transaction Nov 3, 2020 Mar 11, 2020
4 Insider transaction Oct 30, 2020 Oct 30, 2020
4 Insider transaction Oct 28, 2020 Oct 16, 2020
8-K Current report
Shareholder vote results
Oct 21, 2020 Oct 21, 2020
8-K Current report Oct 15, 2020 Oct 15, 2020
10-Q Quarterly report Sep 14, 2020 Jul 31, 2020
8-K Current report
Results of operations
Sep 14, 2020 Sep 14, 2020
DEFA14A Additional proxy material Sep 11, 2020 —
DEFM14A Filing Sep 11, 2020 —
DEF 14A Proxy statement Aug 28, 2020 Apr 30, 2020
10-K Annual report Jul 28, 2020 Apr 30, 2020
8-K Current report
Results of operations
Jul 27, 2020 Jul 27, 2020
8-K Current report
Unregistered share sale
Mar 30, 2020 Mar 26, 2020
4 Insider transaction Mar 30, 2020 Mar 26, 2020
4 Insider transaction Mar 26, 2020 Mar 24, 2020
4 Insider transaction Mar 26, 2020 Mar 24, 2020
4 Insider transaction Mar 24, 2020 Mar 20, 2020
10-Q Quarterly report Mar 16, 2020 Jan 31, 2020
8-K Current report
Results of operations
Mar 12, 2020 Jan 31, 2020
4 Insider transaction Mar 12, 2020 Mar 11, 2020
4 Insider transaction Mar 10, 2020 Mar 6, 2020
8-K Current report
Regulation FD disclosure
Jan 3, 2020 Jan 3, 2020
10-Q Quarterly report Dec 16, 2019 Oct 31, 2019
8-K Current report
Results of operations
Dec 16, 2019 Dec 16, 2019
4 Insider transaction Dec 4, 2019 Dec 2, 2019
4 Insider transaction Nov 6, 2019 Nov 4, 2019
4 Insider transaction Nov 6, 2019 Nov 4, 2019
4 Insider transaction Nov 6, 2019 Nov 4, 2019
4 Insider transaction Nov 6, 2019 Nov 4, 2019
4 Insider transaction Nov 6, 2019 Nov 4, 2019
4 Insider transaction Nov 6, 2019 Nov 4, 2019
8-K Current report
Shareholder vote results
Oct 16, 2019 Oct 16, 2019
10-Q Quarterly report Sep 16, 2019 Jul 31, 2019
8-K Current report
Results of operations
Sep 16, 2019 Sep 16, 2019
8-K Current report
Regulation FD disclosure
Sep 5, 2019 Sep 5, 2019
DEF 14A Proxy statement Aug 28, 2019 Apr 30, 2019
10-K Annual report Jul 29, 2019 Apr 30, 2019
8-K Current report
Results of operations
Jul 15, 2019 Jul 15, 2019
4 Insider transaction Apr 30, 2019 Jan 8, 2019

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
CSBR (Nasdaq)
Fiscal year ends
April 30
Incorporated in
DE
Headquarters
Baltimore, MD
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
771856
Former names
CHAMPIONS BIOTECHNOLOGY, INC. (until Mar 30, 2011); CHAMPIONS SPORTS INC (until Feb 16, 2007)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.